Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification.
David T. Liss, PhD
Advertisement
Articles by David T. Liss, PhD
Adults with type 2 diabetes who received nonsulfonylurea medications had relative increases in total costs. Receiving newer medication classes led to relatively decreased medical costs.
Patients with rheumatoid arthritis self-report a moderate rate of any previous pneumococcal vaccination (54%) and a very low rate of herpes zoster vaccination (8%).
This study investigated healthcare quality, utilization, and costs among patients with common chronic illnesses in a patient-centered medical home prototype redesign.
Advertisement
Latest Updated Articles
- Costs for Commercially Insured Adults Prescribed Second-line Diabetes Medications
Published: March 9th 2021 | Updated:
Treatment Modification After Initiating Second-Line Medication for Type 2 DiabetesPublished: December 12th 2023 | Updated:
- Understanding Vaccination Rates and Attitudes Among Patients With Rheumatoid Arthritis
Published: March 17th 2016 | Updated:
- Outcomes Among Chronically Ill Adults in a Medical Home Prototype
Published: October 22nd 2013 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
5 Consequences If ACA Premium Subsidies End in 2026
2
Raludotatug Deruxtecan Demonstrates Promising Efficacy, Safety in Platinum-Resistant Ovarian Cancer
3
Team-Based Precision Oncology: Advancing Value and Access in Cancer Care
4
Navigating Costs and Logistics of Cellular Therapies, ADCs, and Novel Diagnostics in Cancer Care
5
